Current investigations into retatrutide, a dual stimulant for GLP-1 and GIP receptors, are revealing promising effects in treating weight gain and type 2 condition. Preclinical data suggest a unique action contributing https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/